Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0614620200760050261
Korean Journal of Gastroenterology
2020 Volume.76 No. 5 p.261 ~ p.264
Oxaliplatin-induced Sudden Hearing Loss in a Patient with Pancreatic Cancer
Kim Sung-Bum

Kim So-Yeong
Kim Kook-Hyun
Kim Tae-Nyeun
Abstract
Oxaliplatin is a new generation of platinum derivatives used frequently to treat solid organ malignancies, including colorectal and ovarian cancer. Recently, an oxaliplatin-based chemotherapeutic regimen was adopted for advanced pancreatic cancer. Although oxaliplatin has extensive therapeutic potential, its use can be limited by significant adverse effects, particularly ototoxicity. This paper reports a rare case of irreversible unilateral hearing loss in a 48-year-old female that developed after the intravenous infusion of oxaliplatin during pancreatic cancer treatment. To the best of the authors¡¯ knowledge, this is the second reported case of oxaliplatin-related ototoxicity in pancreatic cancer.
KEYWORD
Ototoxicity, Oxaliplatin, Chemotherapy, Pancreatic neoplasms
FullTexts / Linksout information
 
Listed journal information
MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø